House Vote On SSC Construction Funds Seen As Major Step For Texas Project

WASHINGTON-A recent decision by the U.S. House of Representatives to spend $110 million to begin construction of the superconducting supercollider is expected to break a political and financial logjam that has stymied advocates of the 53-mile-long laboratory. The lopsided House vote on June 28 (see page 11 for excerpts of that debate) has been greeted by SSC backers as the first tangible commitment by Congress to build the $6 billion accelerator. Although the mammoth project must now clear a sim

Written byJeffrey Mervis
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

"Getting funds for construction does three things for us," says Raphael Kasper, associate director of the SSC laboratory in Waxahachie, Tex. "It will make it easier to recruit people, it will facilitate negotiations with foreign governments for their contribution to the project, and it will trigger matching funds from the state of Texas."

The SSC allocation is tucked into an $18.5 billion appropriations bill approved the same day by the House that covers the Department of Energy and various water projects. The bill includes $90 million to continue research on the superconducting magnets that will drive the twin proton beams into their 40 trillion electron-volt collisions.

SSC officials, while happy with the House vote, hasten to add that the project is still in its infancy. So far, they have hired only about 190 of the expected 2,500 scientists, technicians, and support personnel who will be needed to operate the facility, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies